Table 1

Clinical characteristics according to ABSI quartiles in patients with type 2 diabetes

 ABSI Q1(N=153)ABSI Q2(N=151)ABSI Q3(N=151)ABSI Q4(N=152)p Value*
Mean(SD)Mean(SD)Mean(SD)Mean(SD)
Age (years)59(13)63(11)65(12)69(12)<0.001
Gender (% male)627062450.001
SBP (mm Hg)129(19)132(18)128(17)131(20)0.216
DBP (mm Hg)76(12)77(13)76(11)74(12)0.403
HbA1c (mmol/L)72.8(21.4)72.2(19.3)76.0(19.4)72.1(19.5)0.410
HbA1c (%)8.8(2.0)8.7(1.8)9.0(2.0)8.8(1.9)
HDL-C (mmol/L)1.25(0.41)1.24(0.33)1.23(0.39)1.31(0.34)0.252
LDL-C (mmol/L)2.91(0.91)3.03(1.02)2.82(0.78)2.94(0.86)0.238
Triglycerides (mmol/L)1.45(1.10 to 1.81)1.47(1.16 to 1.77)1.51(1.08 to 1.99)1.45(1.32 to 1.56)0.613
Urinary C peptide (μg/day)47.1(42.9 to 51.4)48.4(44.7 to 52.0)45.8(41.6 to 50.0)33.9(30.8 to 37.0)0.001
DM duration (years)12(10)12(10)12(9)15(10)0.044
Urinary albumin (mg/day)28.5(15 to 42)27.7(19 to 37)17.6(16 to 19)20.9(12 to 30)0.014
eGFR (mL/min/1.73 m2)73.6(24.8)72.0(24.5)70.4(23.8)70.9(28.9)0.691
PDR (%)121214150.726
CV-RR (%)4.3(2.4)4.2(2.3)3.8(2.3)3.3(2.0)0.003
baPWV (cm/s)1611(349)1702(520)1713(356)1806(393)0.001
History of CVD (%)141415160.946
  • Data are expressed as mean (SD), geometric mean (95% CI) or percentage as appropriate.

  • *ANOVA or χ2 test.

  • ABSI, A Body Shape Index; ANOVA, analysis of variance; baPWV, brachial-ankle pulse wave velocity; CVD, cardiovascular disease; CV-RR, coefficient of variation of R-R intervals; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PDR, proliferative diabetic retinopathy; SBP, systolic blood pressure.